Informatics tools to assess the success of procedural harmonization in preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis.


Journal

Epilepsy research
ISSN: 1872-6844
Titre abrégé: Epilepsy Res
Pays: Netherlands
ID NLM: 8703089

Informations de publication

Date de publication:
02 2019
Historique:
received: 02 11 2018
revised: 11 12 2018
accepted: 26 12 2018
pubmed: 4 1 2019
medline: 19 6 2019
entrez: 4 1 2019
Statut: ppublish

Résumé

The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) is a National Institutes for Neurological Diseases and Stoke funded Centers-Without-Walls international multidisciplinary study aimed at preventing epileptogenesis. The preclinical biomarker discovery in EpiBios4Rx applies a multicenter study design to allow the number of animals that are required for adequate statistical power for the analysis to be studied in an efficient manner. Further, the use of multiple centers mimics the clinical trial situation, and therefore potentially the chance of successful clinical translation of the outcomes of the study. Its successful implementation requires harmonization of procedures and data analyses between the three contributing centers in Finland, Australia, and USA. The objective of the present analysis was to develop metrics for analysis of the success of harmonization of procedures to guide further data analyses and plan the future multicenter preclinical studies. The interim analysis of data is based on the analysis of data from 212 rats with lateral fluid-percussion injury or sham-operation included in the biomarker discovery by April 30, 2018. The details of protocols, including production of injury, post-injury follow-up, blood sampling, electroencephalogram recording, and magnetic resonance imaging have been presented in the accompanying manuscripts in this Supplement. Implementation of protocols in EpiBios4Rx project participant centers was visualized in 2D using t-distributed stochastic neighborhood embedding (t-SNE). The protocols applied to each rat were presented as feature vectors of procedure related variables (e.g., impact pressure, anesthesia time). The total number of protocol features linked to each rat was 112. The missing data was accounted in visualization by utilizing imputation and adding the number of missing values as a third dimension to 2D t-SNE plot, resulting in a 3D overview of protocol data. Intraclass correlation coefficient (ICC) using Euclidean distances and area under receiver operating characteristic curve (AUC) of k-nearest neighbor classifier (KNN) were utilized to quantify the degree of clustering by center. Both subsets of data with incomplete protocol vectors omitted and missing protocol data imputed were assessed. Our data show that a visible clustering by center was observed in all t-SNE plots, except for day 7 neuroscores. Both ICC and AUC indicated clustering by center in all protocol variable subsets, excluding unimputed day 7 neuroscores (ICC 0.04 and AUC 0.6). ICC for imputed set of all protocol related variables was 0.1 and KNN AUC 0.92. In conclusion, both ICC and AUC indicated differences in protocol between EpiBios4Rx participating centers, which needs to be taken into account in data analysis. Importantly, the majority of observed differences are recoverable as they relate to insufficient updates in record keeping. While AUC score of KNN is a more sensitive measure for protocol harmonization than ICC for data that displays complex splintered clustering, ICC and AUC provide complementary measures to assess the degree of procedural harmonization. This experience should be helpful for other groups planning such multicenter post-traumatic epileptogenesis studies in the future.

Identifiants

pubmed: 30605864
pii: S0920-1211(18)30477-7
doi: 10.1016/j.eplepsyres.2018.12.010
pmc: PMC6818710
mid: NIHMS1054607
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-26

Subventions

Organisme : NINDS NIH HHS
ID : U54 NS100064
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

Epilepsy Res. 2017 Oct;136:18-34
pubmed: 28753497
Epilepsy Res. 2017 Jan;129:87-90
pubmed: 28038337
J Neurotrauma. 2016 Mar 15;33(6):513-22
pubmed: 26439468
Science. 2000 Dec 22;290(5500):2319-23
pubmed: 11125149
Brain. 2016 Jul;139(Pt 7):1919-38
pubmed: 27289302
Nature. 2012 Oct 11;490(7419):187-91
pubmed: 23060188
Epilepsy Res. 2019 Feb;150:46-57
pubmed: 30641351
Epilepsy Res. 2019 Oct;156:106110
pubmed: 30981541
Stat Methods Med Res. 2007 Jun;16(3):219-42
pubmed: 17621469
J Trauma. 2011 Jul;71(1 Suppl):S15-24
pubmed: 21795873
Ann Intern Med. 2001 Jul 17;135(2):112-23
pubmed: 11453711
Neurobiol Dis. 2019 Mar;123:42-58
pubmed: 29782966
Contemp Clin Trials. 2012 Sep;33(5):869-80
pubmed: 22627076
J Neurotrauma. 2019 Jan 15;36(2):348-359
pubmed: 29987972
Epilepsy Res. 2019 Jan;149:92-101
pubmed: 30553097
Epilepsia. 2017 Nov;58 Suppl 4:78-86
pubmed: 29105074
Lancet Neurol. 2017 Dec;16(12):987-1048
pubmed: 29122524
J Neurotrauma. 2015 Nov 15;32(22):1725-35
pubmed: 26058402
BMC Med Res Methodol. 2014 Feb 10;14:20
pubmed: 24512175
Epilepsy Res. 2019 Mar;151:7-16
pubmed: 30711714
PLoS One. 2013 May 14;8(5):e64078
pubmed: 23691153
Stat Med. 2003 Dec 30;22(24):3805-21
pubmed: 14673940

Auteurs

Robert Ciszek (R)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland. Electronic address: ciszek@uef.fi.

Xavier Ekolle Ndode-Ekane (XE)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Cesar Santana Gomez (CS)

Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Pablo M Casillas-Espinosa (PM)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Victoria, 3052, Australia.

Idrish Ali (I)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Victoria, 3052, Australia.

Gregory Smith (G)

Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Noora Puhakka (N)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Niina Lapinlampi (N)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Pedro Andrade (P)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Alaa Kamnaksh (A)

Department of Anatomy, Physiology and Genetics, Uniformed Services University, MD, USA.

Riikka Immonen (R)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Tomi Paananen (T)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Matthew R Hudson (MR)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Victoria, 3052, Australia.

Rhys D Brady (RD)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Victoria, 3052, Australia.

Sandy R Shultz (SR)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia.

Terence J O'Brien (TJ)

Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Victoria, 3052, Australia; Department of Neurology, The Alfred Hospital, Commercial Road, Melbourne, Victoria, 3004, Australia; Department of Neurology, The Royal Melbourne Hospital, Grattan Street, Parkville, Victoria, 3050, Australia.

Richard J Staba (RJ)

Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Jussi Tohka (J)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Asla Pitkänen (A)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH